SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: timmask who wrote (253)8/4/1997 2:17:00 PM
From: Ken Crooks   of 834
 
Tim, I'm not about to "forsee" such, but their loss last qtr was 5% less than expected, due to decreased R&D costs and slight decreases in the general and administrative expenses. We're dealing with a company with losses expected all the way through 98 at least, it's the nature of the beast. In my limited understanding, the way a company like this scores big is through development hits which decrease its losses significantly. Meanwhile, price improvement can only occur through efficiencies.
BTW, Zacks, though it only has two analysts following TXB, are still rating TXB as a strong buy - for whatever that's worth.

Maybe someone more savy can improve on this response!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News